We are live on ! Find out more
AZN icon

AstraZeneca
AZN

449 hedge funds and large institutions have $10.8B invested in AstraZeneca in 2016 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 154 increasing their positions, 120 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

308% more call options, than puts

Call options by funds: $138M | Put options by funds: $33.7M

228% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 25

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

28% more repeat investments, than reductions

Existing positions increased: 154 | Existing positions reduced: 120

24% more capital invested

Capital invested by funds: $8.72B → $10.8B (+$2.1B)

13% more funds holding

Funds holding: 397 → 449 (+52)

1.66% more ownership

Funds ownership: 11.43% → 13.09% (+1.7%)

Holders
449
Holders Change
+52
Holders Change %
+13.1%
% of All Funds
11.98%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.19%
New
82
Increased
154
Reduced
120
Closed
25
Calls
$138M
Puts
$33.7M
Net Calls
+$104M
Net Calls Change
+$35.1M

Top Buyers

1
Dodge & Cox
Dodge & Cox
California
+$316M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$180M
3
ClearBridge Investments
ClearBridge Investments
New York
+$171M
4
Bank of America
Bank of America
North Carolina
+$146M
5
Viking Global Investors
Viking Global Investors
Connecticut
+$136M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$212M
2
CI
Cambiar Investors
Colorado
-$93.2M
3
JP Morgan Chase
JP Morgan Chase
New York
-$42.5M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$31.8M
5
HI
Honeywell International
North Carolina
-$25.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
76
Norges Bank
Norway
$9.44M – – –
AC
77
Ascend Capital
California
$9.23M +$1.77M +27,032 +24%
Janney Montgomery Scott
78
Janney Montgomery Scott
Pennsylvania
$9.12M +$9.07M +138,702 New
GT
79
Glenmede Trust
Pennsylvania
$9.09M -$113K -1,731 -1%
BIT
80
BlackRock Institutional Trust
California
$8.35M +$8.3M +127,020 New
TAM
81
Todd Asset Management
Kentucky
$8.29M +$7.54M +115,409 +1,078%
KIC
82
Keating Investment Counselors
Florida
$8.2M +$7.77M +118,862 +1,993%
ED
83
Exane Derivatives
France
$8.06M +$8.02M +122,638 New
Marshall Wace
84
Marshall Wace
United Kingdom
$7.89M +$7.85M +120,093 New
BTS
85
BB&T Securities
Virginia
$7.37M +$2.4M +36,657 +49%
BlackRock
86
BlackRock
New York
$7.26M +$7.22M +110,438 New
Mirae Asset Global Investments
87
Mirae Asset Global Investments
South Korea
$7.25M +$223K +3,409 +3%
HSBC Holdings
88
HSBC Holdings
United Kingdom
$7.11M -$819K -12,523 -10%
OSAM
89
O'Shaughnessy Asset Management
Connecticut
$6.87M +$1.92M +29,412 +39%
SGH
90
Sivik Global Healthcare
Connecticut
$6.57M +$2.94M +45,000 +82%
SFM
91
Sphera Funds Management
Israel
$6.57M +$6.54M +100,000 New
Barclays
92
Barclays
United Kingdom
$6.26M -$3.33M -51,002 -35%
GCC
93
Guardian Capital (Canada)
Ontario, Canada
$6.25M -$27.5K -421 -0.4%
GF
94
Gabelli Funds
New York
$6.24M -$131K -2,000 -2%
Bank of New York Mellon
95
Bank of New York Mellon
New York
$6.2M +$2.03M +31,058 +49%
GC
96
Guggenheim Capital
Illinois
$6.08M -$348K -5,322 -5%
Allianz Asset Management
97
Allianz Asset Management
Germany
$5.86M -$1.34M -20,497 -19%
Truist Financial
98
Truist Financial
North Carolina
$5.83M +$494K +7,561 +9%
WAM
99
World Asset Management
Michigan
$5.56M +$414K +6,330 +8%
TRSOTSOK
100
Teachers Retirement System of the State of Kentucky
Kentucky
$5.09M +$5.07M +77,500 New
2 3
4
5 6

AZN Hedge Fund Activity: Q3 2016 in Review

449 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2016, worth a combined $10.8B — up 24% from $8.72B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new AZN positions and 25 closed out — a net gain of 57 holders — while 154 added to existing stakes and 120 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $316M. The largest seller was Arrowstreet Capital, cutting an estimated $212M.

  • 449 institutional investors held AstraZeneca (AZN) as of Q3 2016, up from 397 in Q2 2016.
  • Funds reported $10.8B of AstraZeneca stock for Q3 2016, up 24% quarter-over-quarter.
  • 82 funds opened new AstraZeneca positions in Q3 2016 and 25 closed out, a net change of +57 holders.
  • The largest AstraZeneca buyer in Q3 2016 was Dodge & Cox, an estimated $316M added.
  • The largest AstraZeneca seller in Q3 2016 was Arrowstreet Capital, an estimated $212M sold.

Based on aggregated 13F filings for Q3 2016.